Moderna (MRNA) experienced a wild start to 2026, with shares nearly doubling before pulling back 20% from the recent 52-week high. Rick Ducat dives into technical trends to watch and the various support and resistance levels in the stock chart. As for the options flow, Rick talks about the massively outsized move traders experienced Friday.